 | • レポートコード：D0804-14748 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、102ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、緑内障治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。緑内障治療薬の種類別市場規模（縮瞳薬、ベータ遮断薬、アドレナリン作動性アゴニスト、炭酸脱水酵素阻害剤、プロスタグランジン誘導体剤、浸透剤）、用途別市場規模（病院薬局、ドラッグストア、オンライン販売）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Bausch & Lomb, Inc.、Santen、Merck、Fera Pharmaceuticals、Allergan、Teva Pharmaceuticals、Alcon、Akorn, Inc. ・地域別グローバル市場分析 2015年-2020年 ・緑内障治療薬の北米市場（アメリカ、カナダ、メキシコ） ・緑内障治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・緑内障治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・緑内障治療薬の南米市場（ブラジル、アルゼンチン） ・緑内障治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：縮瞳薬、ベータ遮断薬、アドレナリン作動性アゴニスト、炭酸脱水酵素阻害剤、プロスタグランジン誘導体剤、浸透剤 ・用途別分析：病院薬局、ドラッグストア、オンライン販売 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Anti-glaucoma Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Anti-glaucoma Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Anti-glaucoma Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anti-glaucoma Drug market has been segmented into:
Miosis Drugs
Beta-blocker
Adrenergic Agonists
Carbonic Anhydrase Inhibitor
Prostaglandin Derivative Agent
Penetrates
By Application, Anti-glaucoma Drug has been segmented into:
Hospital Pharmacy
Drugstore
Online Sales
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti-glaucoma Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti-glaucoma Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti-glaucoma Drug market.
The report offers in-depth assessment of the growth and other aspects of the Anti-glaucoma Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Anti-glaucoma Drug Market Share Analysis
Anti-glaucoma Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti-glaucoma Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti-glaucoma Drug sales, revenue and market share for each player covered in this report.
The major players covered in Anti-glaucoma Drug are:
Pfizer
Bausch & Lomb, Inc.
Santen
Merck
Fera Pharmaceuticals
Allergan
Teva Pharmaceuticals
Alcon
Akorn, Inc.
Table of Contents
1 Anti-glaucoma Drug Market Overview
1.1 Product Overview and Scope of Anti-glaucoma Drug
1.2 Classification of Anti-glaucoma Drug by Type
1.2.1 Global Anti-glaucoma Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Anti-glaucoma Drug Revenue Market Share by Type in 2019
1.2.3 Miosis Drugs
1.2.4 Beta-blocker
1.2.5 Adrenergic Agonists
1.2.6 Carbonic Anhydrase Inhibitor
1.2.7 Prostaglandin Derivative Agent
1.2.8 Penetrates
1.3 Global Anti-glaucoma Drug Market by Application
1.3.1 Overview: Global Anti-glaucoma Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacy
1.3.3 Drugstore
1.3.4 Online Sales
1.4 Global Anti-glaucoma Drug Market by Regions
1.4.1 Global Anti-glaucoma Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Anti-glaucoma Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Anti-glaucoma Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Anti-glaucoma Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anti-glaucoma Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Anti-glaucoma Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anti-glaucoma Drug Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Anti-glaucoma Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bausch & Lomb, Inc.
2.2.1 Bausch & Lomb, Inc. Details
2.2.2 Bausch & Lomb, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bausch & Lomb, Inc. SWOT Analysis
2.2.4 Bausch & Lomb, Inc. Product and Services
2.2.5 Bausch & Lomb, Inc. Anti-glaucoma Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Santen
2.3.1 Santen Details
2.3.2 Santen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Santen SWOT Analysis
2.3.4 Santen Product and Services
2.3.5 Santen Anti-glaucoma Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Anti-glaucoma Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Fera Pharmaceuticals
2.5.1 Fera Pharmaceuticals Details
2.5.2 Fera Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Fera Pharmaceuticals SWOT Analysis
2.5.4 Fera Pharmaceuticals Product and Services
2.5.5 Fera Pharmaceuticals Anti-glaucoma Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Allergan SWOT Analysis
2.6.4 Allergan Product and Services
2.6.5 Allergan Anti-glaucoma Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Teva Pharmaceuticals
2.7.1 Teva Pharmaceuticals Details
2.7.2 Teva Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Teva Pharmaceuticals SWOT Analysis
2.7.4 Teva Pharmaceuticals Product and Services
2.7.5 Teva Pharmaceuticals Anti-glaucoma Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Alcon
2.8.1 Alcon Details
2.8.2 Alcon Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Alcon SWOT Analysis
2.8.4 Alcon Product and Services
2.8.5 Alcon Anti-glaucoma Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 Akorn, Inc.
2.9.1 Akorn, Inc. Details
2.9.2 Akorn, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Akorn, Inc. SWOT Analysis
2.9.4 Akorn, Inc. Product and Services
2.9.5 Akorn, Inc. Anti-glaucoma Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Anti-glaucoma Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Anti-glaucoma Drug Players Market Share
3.2.2 Top 10 Anti-glaucoma Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Anti-glaucoma Drug Revenue and Market Share by Regions
4.2 North America Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
4.5 South America Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
5 North America Anti-glaucoma Drug Revenue by Countries
5.1 North America Anti-glaucoma Drug Revenue by Countries (2015-2020)
5.2 USA Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
6 Europe Anti-glaucoma Drug Revenue by Countries
6.1 Europe Anti-glaucoma Drug Revenue by Countries (2015-2020)
6.2 Germany Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
6.3 UK Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
6.4 France Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Anti-glaucoma Drug Revenue by Countries
7.1 Asia-Pacific Anti-glaucoma Drug Revenue by Countries (2015-2020)
7.2 China Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
7.5 India Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
8 South America Anti-glaucoma Drug Revenue by Countries
8.1 South America Anti-glaucoma Drug Revenue by Countries (2015-2020)
8.2 Brazil Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Anti-glaucoma Drug by Countries
9.1 Middle East & Africa Anti-glaucoma Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Anti-glaucoma Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Anti-glaucoma Drug Market Forecast by Type (2019-2024)
10.3 Miosis Drugs Revenue Growth Rate (2015-2025)
10.4 Beta-blocker Revenue Growth Rate (2015-2025)
10.5 Adrenergic Agonists Revenue Growth Rate (2015-2025)
10.6 Carbonic Anhydrase Inhibitor Revenue Growth Rate (2015-2025)
10.7 Prostaglandin Derivative Agent Revenue Growth Rate (2015-2025)
10.8 Penetrates Revenue Growth Rate (2015-2025)
11 Global Anti-glaucoma Drug Market Segment by Application
11.1 Global Anti-glaucoma Drug Revenue Market Share by Application (2015-2020)
11.2 Anti-glaucoma Drug Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacy Revenue Growth (2015-2020)
11.4 Drugstore Revenue Growth (2015-2020)
11.5 Online Sales Revenue Growth (2015-2020)
12 Global Anti-glaucoma Drug Market Size Forecast (2021-2025)
12.1 Global Anti-glaucoma Drug Market Size Forecast (2021-2025)
12.2 Global Anti-glaucoma Drug Market Forecast by Regions (2021-2025)
12.3 North America Anti-glaucoma Drug Revenue Market Forecast (2021-2025)
12.4 Europe Anti-glaucoma Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Anti-glaucoma Drug Revenue Market Forecast (2021-2025)
12.6 South America Anti-glaucoma Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Anti-glaucoma Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Anti-glaucoma Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-glaucoma Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-glaucoma Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Anti-glaucoma Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Anti-glaucoma Drug Major Business
Table 7. Pfizer Anti-glaucoma Drug Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Anti-glaucoma Drug Product and Solutions
Table 10. Pfizer Anti-glaucoma Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bausch & Lomb, Inc. Corporate Information, Location and Competitors
Table 12. Bausch & Lomb, Inc. Anti-glaucoma Drug Major Business
Table 13. Bausch & Lomb, Inc. Anti-glaucoma Drug Total Revenue (USD Million) (2018-2019)
Table 14. Bausch & Lomb, Inc. SWOT Analysis
Table 15. Bausch & Lomb, Inc. Anti-glaucoma Drug Product and Solutions
Table 16. Bausch & Lomb, Inc. Anti-glaucoma Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Santen Corporate Information, Location and Competitors
Table 18. Santen Anti-glaucoma Drug Major Business
Table 19. Santen Anti-glaucoma Drug Total Revenue (USD Million) (2017-2018)
Table 20. Santen SWOT Analysis
Table 21. Santen Anti-glaucoma Drug Product and Solutions
Table 22. Santen Anti-glaucoma Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck Corporate Information, Location and Competitors
Table 24. Merck Anti-glaucoma Drug Major Business
Table 25. Merck Anti-glaucoma Drug Total Revenue (USD Million) (2017-2018)
Table 26. Merck SWOT Analysis
Table 27. Merck Anti-glaucoma Drug Product and Solutions
Table 28. Merck Anti-glaucoma Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Fera Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Fera Pharmaceuticals Anti-glaucoma Drug Major Business
Table 31. Fera Pharmaceuticals Anti-glaucoma Drug Total Revenue (USD Million) (2017-2018)
Table 32. Fera Pharmaceuticals SWOT Analysis
Table 33. Fera Pharmaceuticals Anti-glaucoma Drug Product and Solutions
Table 34. Fera Pharmaceuticals Anti-glaucoma Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Allergan Corporate Information, Location and Competitors
Table 36. Allergan Anti-glaucoma Drug Major Business
Table 37. Allergan Anti-glaucoma Drug Total Revenue (USD Million) (2017-2018)
Table 38. Allergan SWOT Analysis
Table 39. Allergan Anti-glaucoma Drug Product and Solutions
Table 40. Allergan Anti-glaucoma Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Teva Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Teva Pharmaceuticals Anti-glaucoma Drug Major Business
Table 43. Teva Pharmaceuticals Anti-glaucoma Drug Total Revenue (USD Million) (2017-2018)
Table 44. Teva Pharmaceuticals SWOT Analysis
Table 45. Teva Pharmaceuticals Anti-glaucoma Drug Product and Solutions
Table 46. Teva Pharmaceuticals Anti-glaucoma Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Alcon Corporate Information, Location and Competitors
Table 48. Alcon Anti-glaucoma Drug Major Business
Table 49. Alcon Anti-glaucoma Drug Total Revenue (USD Million) (2017-2018)
Table 50. Alcon SWOT Analysis
Table 51. Alcon Anti-glaucoma Drug Product and Solutions
Table 52. Alcon Anti-glaucoma Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Akorn, Inc. Corporate Information, Location and Competitors
Table 54. Akorn, Inc. Anti-glaucoma Drug Major Business
Table 55. Akorn, Inc. Anti-glaucoma Drug Total Revenue (USD Million) (2017-2018)
Table 56. Akorn, Inc. SWOT Analysis
Table 57. Akorn, Inc. Anti-glaucoma Drug Product and Solutions
Table 58. Akorn, Inc. Anti-glaucoma Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Anti-glaucoma Drug Revenue (Million USD) by Players (2015-2020)
Table 60. Global Anti-glaucoma Drug Revenue Share by Players (2015-2020)
Table 61. Global Anti-glaucoma Drug Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Anti-glaucoma Drug Revenue Market Share by Regions (2015-2020)
Table 63. North America Anti-glaucoma Drug Revenue by Countries (2015-2020)
Table 64. North America Anti-glaucoma Drug Revenue Market Share by Countries (2015-2020)
Table 65. Europe Anti-glaucoma Drug Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Anti-glaucoma Drug Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Anti-glaucoma Drug Revenue by Countries (2015-2020)
Table 68. South America Anti-glaucoma Drug Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Anti-glaucoma Drug Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Anti-glaucoma Drug Revenue Market Share by Countries (2015-2020)
Table 71. Global Anti-glaucoma Drug Revenue (Million USD) by Type (2015-2020)
Table 72. Global Anti-glaucoma Drug Revenue Share by Type (2015-2020)
Table 73. Global Anti-glaucoma Drug Revenue Forecast by Type (2021-2025)
Table 74. Global Anti-glaucoma Drug Revenue by Application (2015-2020)
Table 75. Global Anti-glaucoma Drug Revenue Share by Application (2015-2020)
Table 76. Global Anti-glaucoma Drug Revenue Forecast by Application (2021-2025)
Table 77. Global Anti-glaucoma Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Anti-glaucoma Drug Picture
Figure 2. Global Anti-glaucoma Drug Revenue Market Share by Type in 2019
Figure 3. Miosis Drugs Picture
Figure 4. Beta-blocker Picture
Figure 5. Adrenergic Agonists Picture
Figure 6. Carbonic Anhydrase Inhibitor Picture
Figure 7. Prostaglandin Derivative Agent Picture
Figure 8. Penetrates Picture
Figure 9. Anti-glaucoma Drug Revenue Market Share by Application in 2019
Figure 10. Hospital Pharmacy Picture
Figure 11. Drugstore Picture
Figure 12. Online Sales Picture
Figure 13. Global Anti-glaucoma Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Anti-glaucoma Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Anti-glaucoma Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Anti-glaucoma Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Anti-glaucoma Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Anti-glaucoma Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Anti-glaucoma Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Anti-glaucoma Drug Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Anti-glaucoma Drug Revenue Market Share in 2019
Figure 22. Global Top 10 Players Anti-glaucoma Drug Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Anti-glaucoma Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Anti-glaucoma Drug Revenue Market Share by Regions (2015-2020)
Figure 26. Global Anti-glaucoma Drug Revenue Market Share by Regions in 2018
Figure 27. North America Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 28. Europe Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 30. South America Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 32. North America Anti-glaucoma Drug Revenue Market Share by Countries (2015-2020)
Figure 33. North America Anti-glaucoma Drug Revenue Market Share by Countries in 2019
Figure 34. USA Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 35. Canada Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 37. Europe Anti-glaucoma Drug Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Anti-glaucoma Drug Revenue Market Share by Countries in 2019
Figure 39. Germany Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 40. UK Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 41. France Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 42. Russia Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 43. Italy Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Anti-glaucoma Drug Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Anti-glaucoma Drug Revenue Market Share by Countries in 2019
Figure 46. China Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 47. Japan Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 48. Korea Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 49. India Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 51. South America Anti-glaucoma Drug Revenue Market Share by Countries (2015-2020)
Figure 52. South America Anti-glaucoma Drug Revenue Market Share by Countries in 2019
Figure 53. Brazil Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Anti-glaucoma Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Anti-glaucoma Drug Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 58. UAE Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Anti-glaucoma Drug Revenue and Growth Rate (2015-2020)
Figure 61. Global Anti-glaucoma Drug Revenue Share by Type (2015-2020)
Figure 62. Global Anti-glaucoma Drug Revenue Share by Type in 2019
Figure 63. Global Anti-glaucoma Drug Market Share Forecast by Type (2021-2025)
Figure 64. Global Miosis Drugs Revenue Growth Rate (2015-2020)
Figure 65. Global Beta-blocker Revenue Growth Rate (2015-2020)
Figure 66. Global Adrenergic Agonists Revenue Growth Rate (2015-2020)
Figure 67. Global Carbonic Anhydrase Inhibitor Revenue Growth Rate (2015-2020)
Figure 68. Global Prostaglandin Derivative Agent Revenue Growth Rate (2015-2020)
Figure 69. Global Penetrates Revenue Growth Rate (2015-2020)
Figure 70. Global Anti-glaucoma Drug Revenue Share by Application (2015-2020)
Figure 71. Global Anti-glaucoma Drug Revenue Share by Application in 2019
Figure 72. Global Anti-glaucoma Drug Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospital Pharmacy Revenue Growth Rate (2015-2020)
Figure 74. Global Drugstore Revenue Growth Rate (2015-2020)
Figure 75. Global Online Sales Revenue Growth Rate (2015-2020)
Figure 76. Global Anti-glaucoma Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Anti-glaucoma Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Anti-glaucoma Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Anti-glaucoma Drug Revenue Market Forecast (2021-2025)
Figure 80. Europe Anti-glaucoma Drug Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Anti-glaucoma Drug Revenue Market Forecast (2021-2025)
Figure 82. South America Anti-glaucoma Drug Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Anti-glaucoma Drug Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
抗腫瘍薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-tumor Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- 微小侵襲性緑内障手術（MIGS）装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Micro Invasive Glaucoma Surgery (MIGS) Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, …
- 抗血管内皮増殖因子（抗VEGF）薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global marke…
- 抗ウイルス薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Viral Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Viral Drugs market repo…
- 禁煙製品の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anti-Smoking Products market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Smoking Products m…